يعرض 1 - 10 نتائج من 40 نتيجة بحث عن '"Liao, I.-Chia"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Global Health, School of Public Health

    المصدر: PMC

    وصف الملف: application/pdf

    العلاقة: Morbidity and Mortality Weekly Report; Ferdinands JM, Rao S, Dixon BE, et al. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):255-263. Published 2022 Feb 18. doi:10.15585/mmwr.mm7107e2; https://hdl.handle.net/1805/41955Test

  3. 3
    دورية أكاديمية

    المساهمون: Epidemiology, School of Public Health

    المصدر: PMC

    وصف الملف: application/pdf

    العلاقة: Morbidity and Mortality Weekly Report; Link-Gelles R, Levy ME, Gaglani M, et al. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. MMWR Morb Mortal Wkly Rep. 2022;71(29):931-939. Published 2022 Jul 22. doi:10.15585/mmwr.mm7129e1; https://hdl.handle.net/1805/41084Test

  4. 4
    دورية أكاديمية

    المساهمون: Epidemiology, School of Public Health

    المصدر: PMC

    مصطلحات موضوعية: BNT162 vaccine, COVID-19, SARS-CoV-2, Vaccine efficacy, Young adults

    وصف الملف: application/pdf

    العلاقة: BMJ; Ferdinands JM, Rao S, Dixon BE, et al. Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. BMJ. 2022;379:e072141. Published 2022 Oct 3. doi:10.1136/bmj-2022-072141; https://hdl.handle.net/1805/35684Test

  5. 5
  6. 6
    دورية أكاديمية

    المصدر: American Journal of Transplantation ; volume 22, issue 1, page 306-314 ; ISSN 1600-6135

  7. 7
    دورية أكاديمية

    المساهمون: Family Medicine, School of Medicine

    المصدر: Publisher

    وصف الملف: application/pdf

    العلاقة: MMWR. Morbidity and Mortality Weekly Report; Bozio, C. H., Grannis, S. J., Naleway, A. L., Ong, T. C., Butterfield, K. A., DeSilva, M. B., Natarajan, K., Yang, D.-H., Rao, S., Klein, N. P., Irving, S. A., Dixon, B. E., Dascomb, K., Liao, I.-C., Reynolds, S., McEvoy, C., Han, J., Reese, S. E., Lewis, N., … Stenehjem, E. (2021). Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity—Nine States, January–September 2021. MMWR. Morbidity and Mortality Weekly Report, 70(44), 1539–1544. https://doi.org/10.15585/mmwr.mm7044e1Test; 0149-2195, 1545-861X; https://hdl.handle.net/1805/27933Test

  8. 8
    دورية أكاديمية

    المساهمون: Medicine, School of Medicine

    المصدر: Publisher

    وصف الملف: application/pdf

    العلاقة: MMWR. Morbidity and Mortality Weekly Report; Embi, P. J., Levy, M. E., Naleway, A. L., Patel, P., Gaglani, M., Natarajan, K., Dascomb, K., Ong, T. C., Klein, N. P., Liao, I.-C., Grannis, S. J., Han, J., Stenehjem, E., Dunne, M. M., Lewis, N., Irving, S. A., Rao, S., McEvoy, C., Bozio, C. H., … DeSilva, M. B. (2021). Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults—Nine States, January–September 2021. MMWR. Morbidity and Mortality Weekly Report, 70(44), 1553–1559. https://doi.org/10.15585/mmwr.mm7044e3Test; 0149-2195, 1545-861X; https://hdl.handle.net/1805/27935Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المساهمون: Medicine, School of Medicine

    المصدر: PMC

    وصف الملف: application/pdf

    العلاقة: Vaccine; Embi PJ, Levy ME, Patel P, et al. Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine. 2023;41(37):5424-5434. doi:10.1016/j.vaccine.2023.05.038; https://hdl.handle.net/1805/37931Test